Structural Entry Filters:

Search Count: 37

Download
9S6M image
Structure Of Bfl1 In Complex With A Covalent Inhibitor, Alternative Series, Cmpd25
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.43 Å Release Date: 2026-01-14
Classification: APOPTOSIS
Ligands: A1JL2

9QFF image
Structure Of Sos1 In Complex With Compound 3

9BI8 image
Crystal Structure Of Inhibitor Gne-6893 Bound To Hpk1

9BIK image
Crystal Structure Of Inhibitor 1 Bound To Hpk1

9BJ1 image
Crystal Structure Of Inhibitor Gne-6893 Bound To Hpk1

9FKY image
Discovery Of A Series Of Covalent, Cell Active Bfl-1 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.56 Å Release Date: 2024-10-02
Classification: APOPTOSIS
Ligands: A1IDP

9FKZ image
Discovery Of A Series Of Covalent, Cell Active Bfl-1 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.68 Å Release Date: 2024-10-02
Classification: APOPTOSIS
Ligands: A1IDO

9FL0 image
Discovery Of A Series Of Covalent, Cell Active Bfl-1 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.94 Å Release Date: 2024-10-02
Classification: APOPTOSIS
Ligands: A1IDG

7R9L image
Crystal Structure Of Hpk1 In Complex With Compound 2

7R9N image
Crystal Structure Of Hpk1 In Complex With Gne1858

7R9P image
Crystal Structure Of Hpk1 In Complex With Compound 14

7R9T image
Crystal Structure Of Hpk1 In Complex With Compound 17

5HCX image
Egfr Kinase Domain Mutant "Tmlr" With Azabenzimidazole Compound 7

5HCY image
Egfr Kinase Domain Mutant "Tmlr" With 3-Carboxamide Azaindole Compound 13

5HCZ image
Egfr Kinase Domain Mutant "Tmlr" With 3-Azetidinyl Azaindazole Compound 21

5F4N image
Multi-Parameter Lead Optimization To Give An Oral Chk1 Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-Ylmethyl)Amino)-5-(Trifluoromethyl)Pyridin-2-Yl)Amino)Pyrazine-2-Carbonitrile (Cct245737)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Resolution:1.91 Å Release Date: 2016-05-25
Classification: TRANSFERASE
Ligands: 5UY, EDO, GOL

5EM5 image
Egfr Kinase Domain Mutant "Tmlr" With Pyridone Compound 2: 4-[2-(4-Chlorophenyl)Ethylamino]-~{N}-[4-(4-Methylpiperazin-1-Yl)Phenyl]-2-Oxidanylidene-1~{H}-Pyridine-3-Carboxamide

5EM6 image
Egfr Kinase Domain Mutant "Tmlr" With Pyridone Compound 19: 4-[(2-Azanylpyrimidin-4-Yl)Amino]-~{N}-[4-(4-Methylpiperazin-1-Yl)Phenyl]-2-Oxidanylidene-1~{H}-Pyridine-3-Carboxamide

5EM7 image
Egfr Kinase Domain Mutant "Tmlr" With Pyridone Compound 13: 4-[(2-Methoxyphenyl)Amino]-~{N}-[4-(4-Methylpiperazin-1-Yl)Phenyl]-2-Oxidanylidene-1~{H}-Pyridine-3-Carboxamide

5EM8 image
Egfr Kinase Domain With Pyridone Compound 13: 4-[(2-Methoxyphenyl)Amino]-~{N}-[4-(4-Methylpiperazin-1-Yl)Phenyl]-2-Oxidanylidene-1~{H}-Pyridine-3-Carboxamide
Protein Functional Filters:
Feedback Form
Name
Email
Institute
Feedback